BlackRock Amends PacBio Stake, Signals Passive Investment Update
Ticker: PACB · Form: SC 13G/A · Filed: Jan 24, 2024 · CIK: 1299130
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock updated its passive stake in PACB as of year-end 2023.**
AI Summary
BlackRock Inc. filed an amended Schedule 13G/A on January 24, 2024, indicating its ownership of Common Stock in PACIFIC BIOSCIENCES OF CALIFORNIA, INC. as of December 31, 2023. This amendment, number 10, updates previous disclosures regarding BlackRock's passive investment in the company. This matters to investors because BlackRock is a major institutional investor, and changes in its reported holdings can signal shifts in its investment strategy or outlook on Pacific Biosciences, potentially influencing other investors' perceptions of the stock.
Why It Matters
This filing shows BlackRock's updated, passive ownership in Pacific Biosciences, which can influence market sentiment and other institutional investors' decisions.
Risk Assessment
Risk Level: low — This is a routine amendment by a large institutional investor, indicating passive ownership, which typically carries low risk.
Analyst Insight
Investors should note BlackRock's continued, passive stake in Pacific Biosciences, but this filing alone doesn't suggest an immediate buy or sell action. It's a routine update from a major holder.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (company) — the issuer whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 24, 2024 (date) — the filing date of the SC 13G/A
- Amendment No: 10 (number) — the specific amendment number to the Schedule 13G
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G, filed under the Securities Exchange Act of 1934.
Who is the filer of this SC 13G/A?
The filer of this SC 13G/A is BlackRock Inc., located at 50 Hudson Yards, New York, NY 10001.
What company's securities are the subject of this filing?
The subject company is PACIFIC BIOSCIENCES OF CALIFORNIA, INC., located at 1305 O'Brien Drive, Menlo Park, CA 94025.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023.
Under which rule is this Schedule 13G/A filed?
This Schedule 13G/A is filed under Rule 13d-1(b), as indicated by the 'X' in the appropriate box.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 24, 2024 regarding PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB).